Search clinical trials for: isoniazid, rifampin, pyrazinamide

Total 591 results

University of Washington
National Institute of Allergy and Infectious Diseases (NIAID); Human Sciences...

Recruiting

ThiPhiSA: New Pathways to Prevention From Community TB Screening in South Africa (ThiPhiSA)

Tuberculosis

South Africa
TASK Applied Science

Recruiting

A Phase 2 Trial to Evaluate the EBA, Safety and Tolerability of Eto Alone and in Combination With BVL-GSK098 (BETO)

Rifampicin- and Isoniazid-Susceptible Pulmonary Tuberculosis (TB)

South Africa
Orient Pharma Co., Ltd.
National Defense Medical Center, Taiwan; National Research Program for Biopharmaceuticals...

Completed

Efficacy of HUEXC030 in Subjects With Pulmonary Tuberculosis

Pulmonary Tuberculosis

Taiwan
Dr. Falk Pharma GmbH

Completed

Rifamycin SV-MMX® 400 mg b.i.d. vs. Rifamycin SV-MMX® 600 mg t.i.d. vs. Placebo in Acute Uncomplicated Diverticulitis

Uncomplicated Diverticulitis

Germany
Pfizer

Completed

A Study To Investigate The Drug-Drug Interaction Potential Of Rifampin OnThe Investigational Agent Palbociclib (PD-0332991)

Healthy

United States
Huashan Hospital

Completed

Efficacy of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention

Tuberculosis | Silicosis

China
National Institute of Allergy and Infectious Diseases...

Completed

The Treatment of Tuberculosis in HIV-Infected Patients

HIV Infections | Tuberculosis

United States
Médecins Sans Frontières, France
Harvard Medical School (HMS and HSDM); Institute of Tropical Medicine, Belgium and other collaborators

Completed

Evaluating Newly Approved Drugs for Multidrug-resistant TB (endTB)

Tuberculosis, Multidrug-Resistant | Infection, Bacterial | Pulmonary Tuberculoses

Pakistan, Georgia, India, Kazakhstan, Lesotho, Peru, South Africa
National Institute of Allergy and Infectious Diseases...

Completed

Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis

HIV Infections | Tuberculosis

United States
Walter K. Kraft
Merck Sharp & Dohme LLC

Completed

Doravirine, Rifapentine and Isoniazid Interaction (DORIIS)

Latent Tuberculosis | Human Immunodeficiency Virus | Drug Interaction Potentiation | Rifamycins Causing Adverse Effects in Therapeutic Use

United States
Amgen

Completed

A Drug-Drug Interaction Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of Apremilast

Healthy Subjects

United States
Cosmo Technologies Ltd

Completed

Rifamycin SV-MMX® 600 mg Tablets Administered Three or Two Times Daily to Patients With IBS-D

Diarrhea-predominant Irritable Bowel Syndrome

Belgium, Germany, Italy, Spain
St. Stephens Clinical Research

Completed

RIFT: Effect of Rifampicin on Plasma PK of FTC, TAF and Intracellular TFV-DP & FTC-TP (RIFT)

HIV

United Kingdom
Windtree Therapeutics

Completed

Lucinactant for Treatment of Acute Hypoxemic Respiratory Failure in Children up to Two Years Old (KL4-AHRF-01)

Acute Hypoxemic Respiratory Failure

United States, Chile
University of Cape Town
Medical Research Council; University of Stellenbosch; Rockefeller Foundation

Completed

Isoniazid Prophylaxis With Concomitant Cotrimoxazole in HIV-infected Children

Tuberculosis

South Africa
Jiangsu HengRui Medicine Co., Ltd.

Completed

Effect of Rifampicin on the Pharmacokinetics of SHR6390 in Healthy Subjects

Healthy Subjects

China
Shanghai Public Health Clinical Center
Zhejiang University; Yunnan Provincial Infectious Disease Hospital; Shenzhen... and other collaborators

Unknown

Rifampicin vs Rifabutin in HIV/AIDS Patients Combined With Tuberculosis (RRHT)

Tuberculosis, Pulmonary | AIDS

China
University of Cape Town
University of Stellenbosch; University of Cape Town Lung Institute; University... and other collaborators

Completed

An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis (NEXT)

Tuberculosis | Multidrug Resistant Tuberculosis | Extensively-drug Resistant Tuberculosis

South Africa
Astellas Pharma Inc

Completed

Pharmacokinetic Interaction Study to Assess the Effect of Repeat Doses of Rifampin on Mirabegron (YM178) in Healthy Volunteers

Pharmacokinetics of YM178

United States
Centers for Disease Control and Prevention

Completed

Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT (iAdhere)

Latent Tuberculosis Infection

United States, China, South Africa, Spain
McGill University
Canadian Institutes of Health Research (CIHR)

Completed

Rifampin Versus Isoniazid for the Treatment of Latent Tuberculosis Infection in Children (P4v9)

Latent Tuberculosis Infection

Canada, Australia, Benin, Brazil, Ghana, Guinea, Indonesia
McGill University
Canadian Institutes of Health Research (CIHR)

Completed

Randomized Clinical Trial Comparing 4RIF vs. 9INH for LTBI Treatment-effectiveness

Latent Tuberculosis Infection

Canada, Australia, Benin, Brazil, Ghana, Indonesia, Guinea, Korea, Republic of, Saudi Arabia
Phillip Low
National Institute of Neurological Disorders and Stroke (NINDS); Vanderbilt... and other collaborators

Terminated

Study of Rifampicin in Multiple System Atrophy (MSA)

Multiple System Atrophy

United States
Oslo University Hospital

Unknown

Rifampin Combination Therapy Versus Monotherapy in Early Staphylococcal Infections After Total Hip and Knee Arthroplasty

Staphylococcal Infections | Prosthesis-related Infections

Norway
Rutgers, The State University of New Jersey

Recruiting

One-month Latent Tuberculosis Treatment for Renal Transplant Candidates

End Stage Renal Disease | Latent Tuberculosis | Renal Transplant Candidate for Right Kidney | Renal Transplant Candidate for Left Kidney

United States
Bradley Connor

Enrolling by invitation

Efficacy of AEMCOLO (Rifamycin SV MMX) in the Treatment of Small Intestinal Bacterial Overgrowth (SIBO)

Gastrointestinal Disease | Small Intestinal Bacterial Overgrowth | Gastrointestinal Infection

United States
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Recruiting

Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients (PHOENIx MDR-TB)

Tuberculosis, MDR

Haiti, Tanzania, Thailand, Botswana, Brazil, India, Kenya, Peru, Philippines, South Africa, Uganda, Zimbabwe, Vietnam
University of California, San Francisco
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Treatment of Latent TB Infection for Jailed Persons

Tuberculosis

United States
National Institute of Allergy and Infectious Diseases...

Completed

Tuberculosis Prevention for HIV Infected Adults

HIV Infections | Tuberculosis

South Africa
CTI BioPharma
Covance

Completed

Drug-Interaction Study to Evaluate the Effect of Rifampin, a Potent CYP3A4 Inducer, on the Systemic Exposure of Pacritinib in Healthy Subjects

Healthy Subjects

United States
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Abiraterone in Healthy Male Participants

Healthy

Belgium
Austin Health

Completed

The Use of Penicillin Allergy Clinical Decision Rule to Enable Direct Oral Penicillin Challenge (PALACE)

Hypersensitivity, Immediate | Hypersensitivity, Delayed | Hypersensitivity Response

United States, Australia, Canada
Gangnam Severance Hospital

Completed

Colistin-rifampin Combination and Colistin Monotherapy in Extensively Drug-resistant Acinetobacter Baumannii

Acinetobacter Infections | Colistin | Rifampin
Cosmo Technologies Ltd

Completed

Pharmacokinetics and Safety Study of Rifamycin SV-MMX® 600 mg Tablets After Single and Multiple t.i.d. Doses in Healthy Male and Female Volunteers

Healthy
Centers for Disease Control and Prevention
US Department of Veterans Affairs

Completed

TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine

Tuberculosis

United States, Canada
AstraZeneca

Completed

Study to Assess the Effect of Rifampicin on Blood Levels and Safety of AZD9291, in Patients With EGFRm+ NSCLC

Non Small Cell Lung Cancer

Korea, Republic of, Taiwan, United Kingdom, Spain, United States, Netherlands
Henry Ford Health System

Completed

Trial Comparing Efficacy of Treatments for Hidradenitis Suppurativa

Hidradenitis Suppurativa

United States
Universitas Padjadjaran
Radboud University Medical Center; United States Agency for International Development...

Completed

High-dose Rifampicin for the Treatment of Tuberculous Meningitis: a Dose-finding Study (ReDEFINe)

Tuberculosis, Meningeal

Indonesia
Queen Mary University of London
University of Washington; University of Oxford; KEMRI-Wellcome Trust Collaborative... and other collaborators

Not yet recruiting

An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM (Co-SAM)

HIV | Severe Acute Malnutrition | Comorbidities and Coexisting Conditions | Child Malnutrition
University of California, San Francisco
Boston University; Boston Medical Center; Mbarara University of Science and Technology

Completed

Alcohol Drinkers' Exposure to Preventive Therapy for TB (ADEPTT) (ADEPTT)

HIV/AIDS | Tuberculosis | Alcohol Abuse

Uganda
National Institute of Allergy and Infectious Diseases...

Completed

Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)

HIV Infections | Tuberculosis

Brazil, United States, Kenya, Peru, South Africa, Thailand, Botswana, Haiti, Malawi, Zimbabwe
Phillip Brian Smith

Completed

Pharmacokinetics (PK) of Antistaphylococcal Antibiotics in Infants (NICHD-2012-02-Staph Trio) (Staph)

Systemic Infection

United States
St Stephens Aids Trust
United States Agency for International Development (USAID); Mylan Inc.

Unknown

Pharmacokinetics of Efavirenz in the Presence of Rifampicin and Isoniazid

HIV

Uganda, United Kingdom
University of Brasilia
Ministry of Health, Brazil; Conselho Nacional de Desenvolvimento Científico... and other collaborators

Completed

Uniform Multidrug Therapy Regimen for Leprosy Patients (U-MDT)

Leprosy

Brazil
Hunter Holmes Mcguire Veteran Affairs Medical Center

Completed

Rifamycin in Minimal Hepatic Encephalopathy (RIVET)

Hepatic Encephalopathy | Cirrhosis, Liver

United States
Epizyme, Inc.

Completed

Study to Describe the Interaction Between Tazemetostat and Itraconazole and Between Tazemetostat and Rifampin in Participants With Advanced Cancer

Solid Tumor | Mesothelioma | Rhabdoid Tumor | Hematologic Malignancy | Advanced Malignancies | Synovial Sarcoma | Renal Medullary Carcinoma | Diffuse Large B-Cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Non-Hodgkin Lymphoma (NHL) | All Malignancies | Epithelioid Sarcoma (ES)

Spain, United States
Hoffmann-La Roche

Completed

A Study to Investigate the Effect of Rifampicin on the PK of Multiple Doses of Balovaptin In Healthy Volunteers

Healthy Volunteers

Netherlands
University of Oulu
Oulu University Hospital

Completed

The Effects of PXR Activation on Hepatic Fat Content

Non-alcoholic Fatty Liver Disease

Finland
Novartis

Completed

Pharmacokinetics and Pharmacodynamics Study of Oral Salmon Calcitonin in Healthy Postmenopausal Women

Postmenopausal Osteoporosis

Denmark
Brigham and Women's Hospital

Withdrawn

The Effect of Vitamin D on Urinary Calcium Excretion in Kidney Stone Formers With High Urinary Calcium

Nephrolithiasis | Vitamin D Deficiency

United States

Search clinical trials for: isoniazid, rifampin, pyrazinamide

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations